Amber Blair, MD
Family Medicine · Ravenna, OHNPI 1710935077
Payments from drug & device makers
Across 48 payments — averaging $118.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$4K
- Arcutis Biotherapeutics, Inc.$710
- Johnson & Johnson$545
- Galderma Laboratories, L.p.$198
- Sun Pharmaceutical Industries Inc.$133
- UCB, Inc.$38
- plus $89 from 3 others
What the payments were for
- Consulting fees$3,76066%
- Food & beverage$1,36124%
- Education$58510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 5 | $3,994 |
| Arcutis Biotherapeutics, Inc. | 6 | $710 |
| Johnson & Johnson | 15 | $545 |
| Galderma Laboratories, L.p. | 12 | $198 |
| Sun Pharmaceutical Industries Inc. | 2 | $133 |
| UCB, Inc. | 1 | $38 |
| LEO Pharma Inc. | 1 | $37 |
| Organon | 5 | $28 |
| Genentech USA, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,706 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 52 | $236,325 |
| Clobetasol Propionate | 102 | $3,357 |
| Ketoconazole | 207 | $3,079 |
| Tacrolimus | 28 | $2,925 |
| Doxycycline Hyclate | 168 | $2,925 |
| Fluorouracil | 29 | $2,547 |
| Metronidazole | 39 | $2,500 |
| Betamethasone Dipropionate | 58 | $2,328 |
| Triamcinolone Acetonide | 160 | $1,606 |
| Calcipotriene | 11 | $1,341 |
| ValacyclovirValacyclovir Hcl | 27 | $1,288 |
| Spironolactone | 75 | $1,192 |
| Doxycycline Monohydrate | 21 | $1,129 |
| Clindamycin Phosphate | 47 | $1,114 |
| Minocycline Hcl | 44 | $534 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ravenna
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.